mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
CCT007093 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.6 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.6 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |